Physician profile
Robert Jay Kruklitis
NPI 1366414252
$148,375.91
in general payments reported to CMS, 2019-2025
26 companies · $25K in 2025
The $25K reported for 2025 was more than what 98% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $22K · 2021: $10K · 2022: $33K · 2023: $8,180 · 2024: $5,814 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $27K · Consulting Fee: $10K · Food and Beverage: $873 · Travel and Lodging: $716 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $27,010.00 |
| Consulting Fee | $10,071.25 |
| Food and Beverage | $872.86 |
| Travel and Lodging | $715.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $365.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $106,629.25 | 2019-2025 | Single Use Suction Valve (Sterile), Single Use Aspiration Needle Na-U401sx, Eves Eus Ultrasound Bronchofibervideoscope |
| Spiration, INC. | $17,702.50 | 2019-2020 | |
| Gyrus Acmi, INC. | $7,956.25 | 2020-2025 | Eves Eus Ultrasound Bronchofibervideoscope, Spiration Valve System |
| Olympus America INC. | $4,243.12 | 2020 | |
| Olympus Medical Systems Corporation | $4,138.44 | 2024 | |
| Veran Medical Technologies, INC. | $2,023.74 | 2022 | |
| Janssen Research & Development, LLC | $1,600.00 | 2019 | |
| Olympus Corporation | $1,368.76 | 2019-2023 | |
| Ethicon INC. | $1,096.86 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,073.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.25 | 2019-2022 | |
| Harmony Biosciences LLC | $72.69 | 2022 | |
| Genentech USA, INC. | $68.26 | 2019-2022 | |
| Glaxosmithkline, LLC. | $54.87 | 2019-2020 | |
| Philips North America LLC | $34.49 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.21 | 2019-2022 | |
| Mylan Specialty L.P. | $20.11 | 2019 | |
| United Therapeutics Corporation | $18.17 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.41 | 2021 | |
| Circassia INC. | $17.09 | 2019 | |
| Shire North American Group INC | $14.34 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.09 | 2019 | |
| Advanced Respiratory, INC | $13.61 | 2019 | |
| Merck Sharp & Dohme LLC | $12.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kruklitis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.